🔥The 9th Round of Easy Loan, Earn $40 Reward is in progress❗️ ⏰ Promotion Period: January 15th - Feburary 15th, 2025 👉 Register now and check more details at gate.io/campaigns/358

Excited to bring the power of RNA liquid biopsy to pregnancy health. 45 million women experience pregnancy complications annually, triple the rate of cancer. Our pioneering team is dedicated to making a difference - early detection…lnkd.in/gFAfNSQ lnkd.in/gbE7-Vj

Mirvie is grateful for support from the Gates Foundation as we innovate to shape the future of predictive and preventive pregnancy health across the globe.

This #landmark research is critical to make meaningful progress in curbing the global maternal mortality crisis. We are grateful to have support from the Gates Foundation in addition to our top-tier venture backers.

In this post, Holly Maloney of General Catalyst and I share how our personal experiences in our respective parenting journeys fuel a head-on reimagining of #PregnancyHealth to fully embrace precision medicine.

We are honored to announce that Mirvie has become the first RNA-based #PregnancyHealth-focused company to receive #CLIA certification. This is a major milestone in our progress toward commercialization and a testament to the clinical quality and accuracy of our technology.

The Mirvie #RNA platform is the result of almost a decade of #landmark research that began in Stephen Quake's lab at Stanford to uncover the drivers of #Preeclampsia and #Preterm birth. We are now leading the way for a new predictive and preventive era for #PregnancyHealth.

Oncology is experiencing the golden age of medicine, but we are failing our moms. American women have the highest rates of preventable pregnancy complications & maternal mortality vs other developed nations. Its time to invest in #PregnancyHealth for a better future for families.

Impressive work, Team Adela!

America is failing moms as maternal mortality rates rise and medical advancements in #PregnancyHealth lag behind. But there is hope, and the market is on the brink of a breakthrough. Women’s health is the next frontier in technology-driven investment.

The mindset around pregnancy complications needs to change from crisis management to knowledge, action, and prevention. This is our goal at Mirvie as we provide women with a window to their unique pregnancy and its risk for complications.

A new chapter for #PregnancyHealth has begun. Mirvie’s study is the largest of its kind with 10,000 participants nationwide. It will give insight into who’s at risk for life-threatening pregnancy complications – a much-needed answer for a worsening maternal health crisis.

Excited to announce that Fast Company named Mirvie one of the #NextBigThingsInTech for 2023! This recognition confirms our dedication to advancing pregnancy health. We are proud to be part of this transformative journey. The future of #pregnancyhealth is here.

Welcome to the team, Susan Hahn! Your deep experience, tenacity and successes will pave the path to making our predictive tests for pregnancy complications accessible to all. We are thrilled to have you join our team and can't wait to see the impact you'll have.

Curbing the growing maternal health crisis requires innovative solutions. Mirvie’s vast and diverse research study will provide much-needed insight for how to predict and prevent life-threatening pregnancy complications.

Investments in women's healthcare create a ripple effect, positively impacting families, healthcare systems, economic productivity & society. In 2024, we must catalyze progress on #womenshealth and #pregnancyhealth. Read more in my conversation with GV’s Cathy Friedman:

There would be no Mirvie without Dr. Stephen Quake. He created the non-invasive NIPT test & then innovated the Mirvie RNA platform to screen for pregnancy complications. A pioneer in #maternalhealth.  Because of his world class science, the future of #pregnancyhealth is bright!"

#caltechditchday